TCRT alaunos.com: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan

The daily price chart for Alaunos Therapeutics (TCRT) shows an EV/EBITDA ratio of 0.00, driven by US trade restrictions on high-tech exports to Asia and stringent biosafety regulations. Current volatility stems from a revision of scientific strategies independent of market cycles. Meanwhile, the business relies on streamlined cryogenic logistics for biomaterials, ensuring process stability and future profitability.

Alaunos Therapeutics, Inc. - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan TCRT (periode 23.11.2025 - 12.11.2026)

alaunos.com (TCRT) - rincian metrik lan laporan keuangan

- rega saham lan target rega konsensus:

Kutipan saham Alaunos Therapeutics, Inc.|TCRT - Rata-rata rega prakiraan

- data kapitalisasi saham perusahaan:

Biji pasar Alaunos Therapeutics, Inc.|TCRT - Nilai Dipunlarasaken Utang lan Kas

- rincian valuasi buku bisnis:

Nilai Buku saben Saham Alaunos Therapeutics|TCRT - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku alaunos.com|TCRT - Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Utang marang Ekuitas Alaunos Therapeutics|TCRT - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Alaunos Therapeutics, Inc.|TCRT - Utang perusahaan|Utang marang nilai buku Alaunos Therapeutics, Inc.|TCRT - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Alaunos Therapeutics|Rasio cepet alaunos.com

- rincian asil keuangan lan kelipatan valuasi:

TCRT - Penghasilan resik perusahaan|Bathi sing dikarepake Alaunos Therapeutics|TCRT - Pangali rega marang bathi|Pangali Forward P/E Alaunos Therapeutics, Inc.|TCRT - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Alaunos Therapeutics, Inc.|TCRT - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Alaunos Therapeutics|TCRT - Bathi saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan alaunos.com|TCRT - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Alaunos Therapeutics

Ringkesan analitik perusahaan:Alaunos (TCRT)

Alaunos Therapeutics (TCRT) leverages the robust R&D potential of leading biochemists, which minimizes personnel risks during immunotherapy development. Analyzing this EV/EBITDA multiple chart, an investor can see the ratio of the company's total value (market capitalization and debt) to its operating profit before interest and taxes. This indicator allows for a real-time assessment of the asset's actual value accounting for debt load, determining the efficiency of investments in the high-tech sector.

Pesaing wigati